| ACTB | Gene encoding beta actin |
| ANOVA | Analysis of variances |
| ATF4 | Activating transcription factor 4 |
| BIP | Binding immunoglobulin protein |
| CHOP | C/EBP homologous protein |
| CM | Conditioned medium |
| CRISPR | Clustered regulatory interspaced short palindromic repeats |
| Cx43 | Connexin 43 |
| CXCL | C-X-C motif chemokine ligand |
| eIF2α | Eukaryotic initiation factor 2 alpha |
| EMT | Epithelial-to-mesenchymal transition |
| ER | Endoplasmic reticulum |
| EV | Empty vector; pCMV-SPORT6-empty construct |
| FBS | Fetal bovine serum |
| GAPDH | Glyceraldehyde 3-phosphate dehydrogenase |
| GJA1 | Gene encoding Gap junction protein alpha 1 gene |
| gRNA | Guide RNA |
| IHC | Immunohistochemistry |
| IL1B | Gene encoding interleukin 1 beta |
| IκBζ | Nuclear factor kappa inhibitor zeta |
| LCN2 | Lipocalin-2 |
| MTT | 4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazoliumbromide |
| NF-κB | Nuclear factor kappa B |
| NGAL | Neutrophil-gelatinase-associated-lipocalin |
| NKBIZ | Gene encoding nuclear factor kappa beta inhibitor zeta |
| PARP | Poly(ADP-ribose)-polymerase |
| PCa | Prostate cancer |
| PCNA | Proliferating cell nuclear antigen |
| PSA | Prostate-specific antigen |
| RT-qPCR | Reverse transcription quantitative polymerase chain reaction |
| TME | Tumor mircoenvironment |
| TUN | Tunicamycin |
| UPR | Unfolded protein response |